Cas no 2566-39-4 (N-L-γ-GLUTAMYL-L-LEUCINE)
N-L-γ-GLUTAMYL-L-LEUCINE Chemical and Physical Properties
Names and Identifiers
-
- N-L-gamma-Glutamyl-L-leucine
- (2S)-2-[[(4S)-4-Amino-5-hydroxy-5-oxopentanoyl]amino]-4-methylpentanoic acid
- H-Glu(Leu-OH)-OH
- H-Γ-GLU-LEU-OH
- N-L-γ-Glutamyl-L-leucine
- gamma-Glu-Leu
- H-g-Glu-Leu-OH
- L-A-GLUTAMYL-L-LEUCINE
- N-L--GLUTAMYL-L-LEUCINE
- Z3244606442
- N-L-?-GLUTAMYL-L-LEUCINE
- (S)-2-Amino-5-(((S)-1-carboxy-3-methylbutyl)amino)-5-oxopentanoic acid
- MFCD00037213
- HY-P4632
- g-Glu-Leu
- SCHEMBL234161
- Q27136932
- CHEBI:68433
- h-gamma-glu-leu-oh
- H-
- CS-0655429
- 2566-39-4
- gamma-Glutamyl-leucine
- A-Glu-Leu-OH
- L-gamma-Glu-L-Leu
- H--Glu-Leu-OH
- L-gamma-glutamyl-L-leucine
- gamma-Glutamylleucine
- AKOS025401632
- L-Leucine, N-L-gamma-glutamyl-
- (2S)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-4-methylpentanoic acid
- AC-23913
- N-L-γ-GLUTAMYL-L-LEUCINE
-
- MDL: MFCD00037213
- Inchi: 1S/C11H20N2O5/c1-6(2)5-8(11(17)18)13-9(14)4-3-7(12)10(15)16/h6-8H,3-5,12H2,1-2H3,(H,13,14)(H,15,16)(H,17,18)/t7-,8-/m0/s1
- InChI Key: MYFMARDICOWMQP-YUMQZZPRSA-N
- SMILES: OC([C@H](CC(C)C)NC(CC[C@@H](C(=O)O)N)=O)=O
Computed Properties
- Exact Mass: 260.13700
- Monoisotopic Mass: 260.137222
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 4
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 18
- Rotatable Bond Count: 9
- Complexity: 317
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 130
- XLogP3: -2.4
Experimental Properties
- Density: 1.238
- Boiling Point: 550.6 °C at 760 mmHg
- Flash Point: 550.6 °C at 760 mmHg
- Refractive Index: 1.513
- PSA: 129.72000
- LogP: 0.88520
N-L-γ-GLUTAMYL-L-LEUCINE Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB476620-1 g |
H-Glu(Leu-OH)-OH; . |
2566-39-4 | 1g |
€401.00 | 2023-07-18 | ||
| TRC | G245140-10mg |
N-L-γ-GLUTAMYL-L-LEUCINE |
2566-39-4 | 10mg |
$ 57.00 | 2023-09-07 | ||
| TRC | G245140-50mg |
N-L-γ-GLUTAMYL-L-LEUCINE |
2566-39-4 | 50mg |
$ 114.00 | 2023-09-07 | ||
| TRC | G245140-100mg |
N-L-γ-GLUTAMYL-L-LEUCINE |
2566-39-4 | 100mg |
$ 167.00 | 2023-09-07 | ||
| Biosynth | FG108034-250 mg |
H-Glu(Leu-OH)-OH |
2566-39-4 | 250MG |
$135.71 | 2023-01-04 | ||
| Biosynth | FG108034-500 mg |
H-Glu(Leu-OH)-OH |
2566-39-4 | 500MG |
$236.78 | 2023-01-04 | ||
| Biosynth | FG108034-1000 mg |
H-Glu(Leu-OH)-OH |
2566-39-4 | 1g |
$408.87 | 2023-01-04 | ||
| Biosynth | FG108034-2000 mg |
H-Glu(Leu-OH)-OH |
2566-39-4 | 2g |
$711.48 | 2023-01-04 | ||
| Biosynth | FG108034-5000 mg |
H-Glu(Leu-OH)-OH |
2566-39-4 | 5g |
$1,546.75 | 2023-01-04 | ||
| eNovation Chemicals LLC | D127564-10mg |
H-GAMMA-GLU-LEU-OH TFA salt |
2566-39-4 | 98% | 10mg |
$198 | 2024-08-03 |
N-L-γ-GLUTAMYL-L-LEUCINE Suppliers
N-L-γ-GLUTAMYL-L-LEUCINE Related Literature
-
Qianxia Liu,Min Yang,Baotang Zhao,Fumin Yang RSC Adv. 2020 10 19844
-
Walter Mier,Susanne Kr?mer,Sabine Zitzmann,Annette Altmann,Karin Leotta,Ursula Schierbaum,Martina Schn?lzer,Michael Eisenhut,Uwe Haberkorn Org. Biomol. Chem. 2013 11 2706
-
Wenzhen Liao,Longjian Gu,Yamei Zheng,Zisheng Zhu,Mouming Zhao,Ming Liang,Jiaoyan Ren Med. Chem. Commun. 2016 7 2083
-
Wan-Qi Qin,Dan Fei,Lei Zhou,Yu-Jia Guo,Shun An,Ou-Hang Gong,Yun-Yang Wu,Jin-Feng Liu,Shi-Zhong Yang,Bo-Zhong Mu New J. Chem. 2023 47 7604
-
Yunsong Jiang,Rui Wang,Zhongtian Yin,Jinyuan Sun,Bowen Wang,Dongrui Zhao,Xin-an Zeng,Hehe Li,Mingquan Huang,Baoguo Sun Food Funct. 2021 12 4808
Additional information on N-L-γ-GLUTAMYL-L-LEUCINE
Comprehensive Guide to N-L-γ-GLUTAMYL-L-LEUCINE (CAS No. 2566-39-4): Properties, Applications, and Research Insights
N-L-γ-Glutamyl-L-leucine (CAS No. 2566-39-4) is a dipeptide compound formed by the conjugation of L-glutamic acid and L-leucine through a γ-glutamyl linkage. This unique structure endows it with notable biochemical properties, making it a subject of interest in nutritional science, cosmetic formulations, and biomedical research. With growing consumer awareness of peptide-based skincare and functional foods, this compound has garnered attention for its potential role in anti-aging, muscle recovery, and cellular hydration.
The γ-glutamyl bond in N-L-γ-Glutamyl-L-leucine distinguishes it from conventional α-linked peptides, offering enhanced stability against enzymatic degradation. This property aligns with current trends in sustainable bioactive ingredients, as researchers explore its applications in nutraceuticals and dermocosmetics. Studies suggest its ability to modulate glutathione metabolism, a hot topic linked to oxidative stress management—a key concern in today’s health-conscious society.
In the cosmetic industry, N-L-γ-Glutamyl-L-leucine is increasingly featured in hydrating serums and barrier repair products. Its molecular structure may support skin moisture retention, addressing frequent consumer searches for "long-lasting hydration" and "natural moisturizing factors." Additionally, its potential role in wound healing and collagen synthesis aligns with the booming demand for science-backed skincare solutions.
From a nutritional perspective, this dipeptide’s bioavailability and amino acid delivery mechanisms are under investigation for sports nutrition formulations. Athletes and fitness enthusiasts searching for "recovery peptides" or "muscle protein synthesis boosters" may find this compound relevant. Preliminary research indicates synergistic effects with other branched-chain amino acids (BCAAs), though further clinical validation is needed.
Quality standards for CAS No. 2566-39-4 emphasize high-purity synthesis via enzymatic catalysis or solid-phase peptide synthesis (SPPS). Analytical methods like HPLC and mass spectrometry ensure compliance with pharmaceutical-grade specifications. As regulatory frameworks evolve for bioactive peptides, manufacturers prioritize GRAS (Generally Recognized As Safe) status and eco-friendly production methods to meet global sustainability goals.
Future research directions for N-L-γ-Glutamyl-L-leucine include exploring its gut-brain axis interactions and immunomodulatory effects—areas gaining traction in personalized medicine. Its compatibility with vegan and clean-label trends further enhances its market potential. For researchers and formulators, understanding its structure-activity relationship remains critical to unlocking novel applications.
2566-39-4 (N-L-γ-GLUTAMYL-L-LEUCINE) Related Products
- 158756-95-7(Hexanoic acid, 6-[[(1S)-1-carboxy-3-methylbutyl]amino]-6-oxo-)
- 124397-74-6(L-Leucine,N-(4-carboxy-1-oxobutyl)-)
- 144301-09-7(Butanoic acid,2-[(4-methyl-1-oxopentyl)amino]-)
- 133906-92-0(Leucine, N-(1-oxohexyl)-)
- 195060-95-8(Leucine,N-(1-oxobutyl)-)
- 14379-43-2(L-Leucine,N-(1-oxooctadecyl)-)
- 14379-40-9(L-Leucine,N-(1-oxododecyl)-)
- 55443-74-8(N-propanoylleucine)
- 3790-55-4(L-L-gamma-Glutamylleucine)
- 80154-63-8(Isovalerylglutamic acid)